• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines N-benzylpiperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Benzylpiperidines N-benzylpiperidines

Professional Introduction to Compound with CAS No. 57611-47-9 and Product Name: 1-Benzyl-3-(methoxycarbonyl)-4-piperidone

The compound identified by the CAS number 57611-47-9 and the product name 1-Benzyl-3-(methoxycarbonyl)-4-piperidone represents a significant area of interest in the field of pharmaceutical chemistry and medicinal biology. This compound, featuring a piperidone core structure, has garnered attention due to its versatile pharmacological properties and potential applications in drug discovery. The presence of both a benzyl group and a methoxycarbonyl moiety in its molecular framework suggests unique interactions with biological targets, making it a valuable candidate for further exploration.

In recent years, the development of novel therapeutic agents has been heavily influenced by the design of molecules that can modulate biological pathways with high specificity and efficacy. The structure of 1-Benzyl-3-(methoxycarbonyl)-4-piperidone aligns well with this trend, as it incorporates functional groups that are known to enhance binding affinity and metabolic stability. This compound has been studied in various contexts, including its potential role as an intermediate in the synthesis of more complex pharmacophores.

One of the most compelling aspects of this compound is its structural similarity to known bioactive molecules. The piperidone scaffold is a common feature in many pharmacologically relevant compounds, often serving as a core structure that interacts with enzymes and receptors. The benzyl group and the methoxycarbonyl group further modify this core, potentially enhancing its interaction with biological targets while minimizing off-target effects. Such modifications are critical in the development of drugs that exhibit high selectivity and low toxicity.

Recent studies have begun to explore the pharmacological potential of derivatives of 1-Benzyl-3-(methoxycarbonyl)-4-piperidone. These investigations have revealed promising results in several therapeutic areas, including anti-inflammatory, analgesic, and neuroprotective applications. The compound's ability to interact with specific biological pathways has been demonstrated through both in vitro and in vivo studies, suggesting its utility as a lead compound for further drug development.

The synthesis of 1-Benzyl-3-(methoxycarbonyl)-4-piperidone involves multi-step organic reactions that highlight the compound's synthetic accessibility. The methoxycarbonyl group, for instance, can be introduced through esterification reactions, while the benzyl group can be incorporated via cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings. These synthetic strategies not only facilitate the production of the compound but also allow for easy modification of its structure, enabling the exploration of various analogs with tailored pharmacological properties.

The chemical stability of 1-Benzyl-3-(methoxycarbonyl)-4-piperidone is another important consideration in its potential application as a pharmaceutical intermediate. The methoxycarbonyl group, while providing enhanced binding interactions, also necessitates careful handling to prevent hydrolysis under certain conditions. However, when stored under appropriate conditions, such as in anhydrous solvents at controlled temperatures, the compound remains stable and suitable for further chemical manipulation.

In conclusion, 1-Benzyl-3-(methoxycarbonyl)-4-piperidone (CAS No. 57611-47-9) represents a promising candidate for drug discovery due to its unique structural features and demonstrated pharmacological activity. Its synthesis is feasible through well-established organic chemistry methods, and its stability under appropriate conditions makes it suitable for further exploration as an intermediate in pharmaceutical development. As research continues to uncover new applications for this compound and its derivatives, it is likely to play an increasingly important role in the development of novel therapeutic agents.

• 17012-21-4(Methyl 1-benzylpyrrolidine-3-carboxylate)
• 72551-53-2(Ethyl 1-benzylpiperidine-3-carboxylate)
• 10315-06-7(Methyl 1-benzylpiperidine-4-carboxylate)
• 50585-91-6(Methyl 1-benzylpiperidine-3-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)